PUVA & Targeted Phototherapy
PUVA and targeted local units treat stubborn sites such as hands, feet and scalp with cortisone-free light. Dose and response are monitored throughout the course.
Clinic and treatment images
Tap to enlargeHow it is applied
A light-sensitising psoralen is followed by UVA, with the dose tailored to skin type.
Targeted local units treat hands, feet and scalp while sparing surrounding healthy skin.
Session time and cumulative dose are logged; eye protection continues through the day.
Response is tracked with PASI/DLQI and the dose or frequency adjusted if needed.
Who it suits
- Selected patients with palmoplantar psoriasis, hand-foot eczema or scalp involvement.
- People with localised, stubborn plaques who respond poorly to narrowband UVB alone.
- Those who prefer a targeted, regional approach rather than whole-body treatment.
PUVA increases light sensitivity, so sun and eye protection are needed afterwards and it is avoided in pregnancy.
Why Clinovia?
Psoriasis and eczema are not only a surface problem. We assess the skin barrier, inflammation, nutrition and lifestyle, comorbidities and dermatological treatment together. Evidence-based dermatology remains the backbone; nutrition and lifestyle support that plan.
The Gut–Skin Relationship
We review digestive symptoms, dietary pattern and food-sensitivity history. The link between gut microbiome and inflammatory skin disease is still being researched, so it is addressed alongside — never instead of — dermatological treatment.
Cortisone-Free Protocol
First-line calcineurin and PDE-4 inhibitors, ceramide-based barrier repair and phototherapy instead of steroids; systemic and biologic steps when needed.
Systemic Repair
Vitamin D, zinc, omega-3 and iron levels plus thyroid and insulin resistance are screened, and any deficits found are built into the plan.
Measurable Follow-up
PASI/EASI and DLQI scores are tracked alongside laboratory values; steps that do not deliver a response are removed from the plan.
Our standard protocols are cortisone-free. We work with topical calcineurin inhibitors, PDE-4 inhibitors, ceramide-based barrier repair, NB-UVB phototherapy and biologic agents when needed. Cortisone is considered only for very short, unavoidable situations and with the patient's consent.
NB-UVB is safe when cumulative dose is monitored. A typical course is 20–30 sessions at two to three per week; the first response usually appears within 4–6 weeks.
Patients with moderate-to-severe psoriasis or severe atopic dermatitis who did not respond adequately to phototherapy and systemic therapy. Eligibility is confirmed after screening tests.
All treatments
NB-UVB PhototherapyNarrowband UVB at 311 nm calms inflammation in psoriasis and eczema without cortisone. Sessions run two to three times a week, with a typical course of 20–30 and PASI/EASI tracking.
Learn more
Biologic TreatmentsBiologic drugs selectively block targets such as IL-17 and IL-23 in psoriasis and IL-4/13 in eczema. They are considered in moderate-to-severe, resistant disease after screening.
Learn more
Systemic TherapySystemic drugs such as methotrexate, cyclosporine and acitretin are used in widespread or resistant psoriasis and eczema, alongside laboratory and safety monitoring.
Learn more
Let's build the right plan for your skin today
Fill in the form and our coordinator will call you the same day to arrange the right doctor and time slot.
- Same-day callback
- Consultation in five languages
- Written treatment plan
- Defterdar, Fethi Çelebi Cd. No:15, 34050 Eyüpsultan/İstanbul, Türkiye
- Mon–Sat: 09:00 – 19:00